|
CC-401 (hydrochloride)
| S83325-5mg | 5mg | MedMol |
|
CC-401 (hydrochloride)
| S83325-10mg | 10mg | MedMol |
|
CC-401 (hydrochloride)
| S83325-50mg | 50mg | MedMol |
|
Carbonic acid, (3S,4R)-1,3-dimethyl-4-[3-(1-methylethoxy)phenyl]-4-piperidinyl ethyl ester (9CI)
| S83331-500mg | 500mg | MedMol |
|
CTX-0294885
| S83332-5mg | 5mg | MedMol |
|
CTX-0294885
| S83332-10mg | 10mg | MedMol |
|
CTX-0294885
| S83332-50mg | 50mg | MedMol |
|
CB1-IN-1
| S83267-5mg | 5mg | MedMol |
|
CB1-IN-1
| S83267-10mg | 10mg | MedMol |
|
CAL-130 (Hydrochloride)
| S83284-5mg | 5mg | MedMol |
|
CAL-130 (Hydrochloride)
| S83284-10mg | 10mg | MedMol |
|
CCT241533 (hydrochloride)
| S83290-5mg | 5mg | MedMol |
|
CCT241533 (hydrochloride)
| S83290-10mg | 10mg | MedMol |
|
CCT241533 (hydrochloride)
| S83290-50mg | 50mg | MedMol |
|
CREB inhibitor (666-15)
| S83304-10mg | 10mg | MedMol |
|
CREB inhibitor (666-15)
| S83304-25mg | 25mg | MedMol |
|
Carbamic acid, N-[[4-[chloro(hydroxyimino)methyl]phenyl]methyl]-N-methyl-, 1,1-dimethylethyl ester
| S83264-1g | 1g | MedMol |
|
CREB inhibitor (666-15)
| S83304-5mg | 5mg | MedMol |
|
CPDA
| S83209-5mg | 5mg | MedMol |
|
CPDA
| S83209-10mg | 10mg | MedMol |
|
Cyclopentanepropanamide, α-amino-N-cyclopropyl-, hydrochloride (1:1), (αS)-
| S83147-100mg | 100mg | MedMol |
|
Cyclopentanepropanamide, α-amino-N-cyclopropyl-, hydrochloride (1:1), (αS)-
| S83147-500mg | 500mg | MedMol |
|
Cyclopentanepropanamide, α-amino-N-cyclopropyl-, (αS)-
| S83148-100mg | 100mg | MedMol |
|
Cyclopentanepropanamide, α-amino-N-cyclopropyl-, (αS)-
| S83148-250mg | 250mg | MedMol |
|
Celgosivir (hydrochloride)
| S83162-1mg | 1mg | MedMol |
|
Celgosivir (hydrochloride)
| S83162-5mg | 5mg | MedMol |
|
Celgosivir (hydrochloride)
| S83162-10mg | 10mg | MedMol |
|
CDK9-IN-1
| S83176-5mg | 5mg | MedMol |
|
CDK9-IN-1
| S83176-10mg | 10mg | MedMol |
|
CDK9-IN-1
| S83176-50mg | 50mg | MedMol |
|
CDK9-IN-1
| S83176-100mg | 100mg | MedMol |
|
Cyclopropanamine, 2-(3,4-difluorophenyl)-, hydrochloride (1:1), (1R,2S)-
| S83123-100mg | 100mg | MedMol |
|
Cyclopropanamine, 2-(3,4-difluorophenyl)-, hydrochloride (1:1), (1R,2S)-
| S83123-1g | 1g | MedMol |
|
Ca2+ channel agonist 1
| S83129-5mg | 5mg | MedMol |
|
Ca2+ channel agonist 1
| S83129-10mg | 10mg | MedMol |
|
Cyclopropanol, 2-(4-penten-1-yl)-,(1R,2R)-rel-
| S83072-250mg | 250mg | MedMol |
|
CEP-37440
| S83088-5mg | 5mg | MedMol |
|
CEP-37440
| S83088-10mg | 10mg | MedMol |
|
CEP-37440
| S83088-50mg | 50mg | MedMol |
|
CDK9-IN-6
| S83090-5mg | 5mg | MedMol |
|
CDK9-IN-6
| S83090-10mg | 10mg | MedMol |
|
Cyclohexanamine, 4-[4-(cyclopropylmethyl)-1-piperazinyl]-, trans-, 4-methylbenzenesulfonate (1:3)
| S83031-250mg | 250mg | MedMol |
|
Cyclohexanamine, 4-[4-(cyclopropylmethyl)-1-piperazinyl]-, trans-, 4-methylbenzenesulfonate (1:3)
| S83031-500mg | 500mg | MedMol |
|
Carbamic acid, N-[[4-(2-propyn-1-yloxy)phenyl]methyl]-, 1,1-dimethylethyl ester
| S83062-100mg | 100mg | MedMol |
|
Carbamic acid, N-[[4-(2-propyn-1-yloxy)phenyl]methyl]-, 1,1-dimethylethyl ester
| S83062-250mg | 250mg | MedMol |
|
Cyclopropanol, 2-(4-penten-1-yl)-,(1R,2R)-rel-
| S83072-100mg | 100mg | MedMol |
|
Cobimetinib (hemifumarate)
| S83016-5mg | 5mg | MedMol |
|
Cobimetinib (hemifumarate)
| S83016-10mg | 10mg | MedMol |
|
Cobimetinib (hemifumarate)
| S83016-50mg | 50mg | MedMol |
|
Carbamic acid, N-[trans-4-[(dimethylamino)methyl]cyclohexyl]-, phenylmethyl ester
| S82969-1g | 1g | MedMol |
